Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study on Human Normal Immunoglobulin and Sodium Chloride to Prevent Infections in Patients with Chronic Lymphocytic Leukemia

    Recruiting

    3 1 1
    Bulgaria Croatia Hungary Poland Romania
  • Study of Lisaftoclax Alone or with Drug Combination for Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

    Recruiting

    1 1 1 1
    Hungary Poland
  • Study of venetoclax plus rituximab in adult patients with relapsed chronic lymphocytic leukemia (CLL) in Poland

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    Poland
  • Rituximab and venetoclax treatment for 6 vs 26 cycles in patients with relapsed or refractory chronic lymphocytic leukemia

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    The Netherlands
  • Safety and efficacy of venetoclax, obinutuzumab and daratumumab in adult patients with relapsed chronic lymphocytic leukemia

    Not yet recruiting

    1 1 1 1
    Poland
  • Study of pirtobrutinib combined with immuno-chemotherapy for previously untreated patients with symptomatic chronic lymphocytic leukemia

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France
  • Study on Lymph Node Changes in Chronic Lymphocytic Leukemia Patients Treated with Venetoclax

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Italy
  • Study Comparing Nemtabrutinib, Ibrutinib, and Acalabrutinib for Patients with Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

    Not yet recruiting

    3 1 1 1
    Spain
  • Evaluation of Safety and Efficacy of Zilovertamab Vedotin and Nemtabrutinib in Aggressive and Indolent B-cell Malignancies

    Not recruiting

    2 1 1
    Czechia Estonia Germany Ireland Italy Poland +3
  • Study on the Effectiveness and Safety of Sonrotoclax and Zanubrutinib for Adults with Untreated Chronic Lymphocytic Leukemia

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Italy Poland Spain